PortfoliosLab logoPortfoliosLab logo
JANX vs. DOGZ
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

JANX vs. DOGZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Janux Therapeutics, Inc. (JANX) and Dogness (International) Corporation (DOGZ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, JANX achieves a -1.52% return, which is significantly higher than DOGZ's -89.72% return.


JANX

1D
-1.38%
1M
-5.76%
YTD
-1.52%
6M
-20.57%
1Y
-46.56%
3Y*
-0.20%
5Y*
10Y*

DOGZ

1D
-1.80%
1M
-8.40%
YTD
-89.72%
6M
-90.05%
1Y
-95.96%
3Y*
-57.70%
5Y*
-49.50%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

JANX vs. DOGZ - Yearly Performance Comparison


2026 (YTD)20252024202320222021
JANX
Janux Therapeutics, Inc.
-1.52%-74.22%398.97%-18.53%-33.25%-21.55%
DOGZ
Dogness (International) Corporation
-89.72%-76.70%793.70%-74.03%-88.35%310.24%

Correlation

The correlation between JANX and DOGZ is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (All Time)
Calculated using the full available price history since Jun 14, 2021

0.08

Fundamentals

Market Cap

JANX:

$851.63M

DOGZ:

$19.41M

EPS

JANX:

-$1.84

DOGZ:

-$0.83

PS Ratio

JANX:

39.07

DOGZ:

0.47

PB Ratio

JANX:

0.90

DOGZ:

0.20

Total Revenue (TTM)

JANX:

$21.61M

DOGZ:

$36.59M

Gross Profit (TTM)

JANX:

$8.44M

DOGZ:

$7.70M

EBITDA (TTM)

JANX:

-$134.03M

DOGZ:

-$6.31M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

JANX vs. DOGZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JANX
JANX Risk / Return Rank: 1717
Overall Rank
JANX Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
JANX Sortino Ratio Rank: 2020
Sortino Ratio Rank
JANX Omega Ratio Rank: 1717
Omega Ratio Rank
JANX Calmar Ratio Rank: 1414
Calmar Ratio Rank
JANX Martin Ratio Rank: 1717
Martin Ratio Rank

DOGZ
DOGZ Risk / Return Rank: 66
Overall Rank
DOGZ Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
DOGZ Sortino Ratio Rank: 66
Sortino Ratio Rank
DOGZ Omega Ratio Rank: 22
Omega Ratio Rank
DOGZ Calmar Ratio Rank: 11
Calmar Ratio Rank
DOGZ Martin Ratio Rank: 1111
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JANX vs. DOGZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Janux Therapeutics, Inc. (JANX) and Dogness (International) Corporation (DOGZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


JANXDOGZDifference

Sharpe ratio

Return per unit of total volatility

-0.63

-0.70

+0.07

Sortino ratio

Return per unit of downside risk

-0.43

-1.51

+1.08

Omega ratio

Gain probability vs. loss probability

0.92

0.71

+0.21

Calmar ratio

Return relative to maximum drawdown

-0.72

-0.99

+0.28

Martin ratio

Return relative to average drawdown

-1.10

-1.30

+0.20

JANX vs. DOGZ - Sharpe Ratio Comparison

The current JANX Sharpe Ratio is -0.63, which is comparable to the DOGZ Sharpe Ratio of -0.70. The chart below compares the historical Sharpe Ratios of JANX and DOGZ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


JANXDOGZDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.63

-0.70

+0.07

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.37

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.09

-0.35

+0.27

Drawdowns

JANX vs. DOGZ - Drawdown Comparison

The maximum JANX drawdown since its inception was -83.14%, smaller than the maximum DOGZ drawdown of -99.42%. Use the drawdown chart below to compare losses from any high point for JANX and DOGZ.


Loading charts...

Drawdown Indicators


JANXDOGZDifference

Max Drawdown

Largest peak-to-trough decline

-83.14%

-99.42%

+16.28%

Max Drawdown (1Y)

Largest decline over 1 year

-64.94%

-96.56%

+31.62%

Max Drawdown (3Y)

Largest decline over 3 years

-81.78%

-98.21%

+16.43%

Max Drawdown (5Y)

Largest decline over 5 years

-99.42%

Current Drawdown

Current decline from peak

-79.67%

-99.38%

+19.71%

Average Drawdown

Average peak-to-trough decline

-52.01%

-72.03%

+20.02%

Ulcer Index

Depth and duration of drawdowns from previous peaks

42.42%

73.64%

-31.22%

Volatility

JANX vs. DOGZ - Volatility Comparison

The current volatility for Janux Therapeutics, Inc. (JANX) is 9.11%, while Dogness (International) Corporation (DOGZ) has a volatility of 15.25%. This indicates that JANX experiences smaller price fluctuations and is considered to be less risky than DOGZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


JANXDOGZDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.11%

15.25%

-6.14%

Volatility (6M)

Calculated over the trailing 6-month period

82.02%

161.37%

-79.35%

Volatility (1Y)

Calculated over the trailing 1-year period

74.22%

137.18%

-62.96%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

131.36%

133.78%

-2.42%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

131.36%

120.69%

+10.67%

Dividends

JANX vs. DOGZ - Dividend Comparison

Neither JANX nor DOGZ has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

JANX vs. DOGZ - Financials Comparison

This section allows you to compare key financial metrics between Janux Therapeutics, Inc. and Dogness (International) Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M20222023202420252026
3.73M
7.71M
(JANX) Total Revenue
(DOGZ) Total Revenue
Values in USD except per share items

Frequently Asked Questions


JANX and DOGZ have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DOGZ has higher volatility (15.25%) compared to JANX (9.11%). In terms of maximum drawdown, JANX dropped -83.14% vs DOGZ's -99.42%.

JANX currently has the higher Sharpe Ratio (-0.63 vs -0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for JANX and DOGZ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer